Walk into almost any wellness clinic or anti-aging practice in the United States and you will find them: vials of compounded ...

Blackstone's Global Head of Private Wealth says education is essential for investors looking to access the benefits of ...

KNOXVILLE, Tenn. — Covenant Health Knoxville Marathon leaders said "various compounding errors" led to runners going a ...

The U.S. FDA appears poised to allow compounding pharmacies to again sell injectable peptides, a class of products with questionable anti-aging and anti-disease benefits that came under scrutiny for ...

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell. By Christina ...

A new study funded by Eli Lilly found that mixing compounded tirzepatide with vitamin B12 can lead to impurities that may pose a patient safety risk. A compounding pharmacy industry group says the ...

Drugmaker Eli Lilly says some copycat versions of its GLP-1 medications pose unique safety concerns — here’s what you need to know. A new study funded by Eli Lilly found that mixing compounded ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly has warned of high levels of an impurity in certain compounded versions of its blockbuster glucagon-like peptide-1 ...

Though it’s hard to say exactly what the future holds for mass GLP-1 compounding, the pressure is mounting from multiple angles in the U.S. as drugmakers and the FDA alike seek to crack down on the ...

Compounded versions of tirzepatide (Mounjaro, Zepbound) containing vitamin B12 pose a potential safety risk to the public, Eli Lilly warned in an open letter on Thursday. Following laboratory testing, ...

You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...

The Food and Drug Administration’s crackdown on cheaper, independently produced versions of popular weight-loss and diabetes medications stoked anger and pushback from users, sellers and the Alliance ...